Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1988-04-05
1989-10-24
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 9, 424 8591, 530402, 530403, 530387, 514 2, 514 21, A61K 4902, A61K 3702, A61K 3944
Patent
active
048760811
ABSTRACT:
Vinyl radiohalogenated small molecules shown in formulas I and II: ##STR1## wherein *X is a radiohalogen, C.dbd.C is a double bonded set of sp.sup.2 hybridized carbon atoms, and substituents R.sub.1, R.sub.2, and Y are as defined below. R.sub.1 and R.sub.2 are substituents independently selected from among hydrogen; alkyl or substituted alkyl, provided that any sp.sup.2 or sp carbon atom substituted on the alkyl is separated from C.dbd.C by at least one fully substituted sp.sup.3 carbon atom; aryl or substituted aryl, provided that the aryl is bonded directly to C.dbd.C; heteroalkyl, provided, first, that no heteroatom of the heteroalkyl bonds directly to C.dbd.C and, second, that any sp.sup.2 or sp hybridized carbon bonded to a heteroatom of the heteroalkyl is not bonded directly to or otherwise conjugated with C.dbd.C and, third, that where a single sp.sup.3 carbon intervenes between C.dbd.C and an sp.sup.2 or sp carbon bonded to a heteroatom, that intervening sp.sup.3 carbon must be fully substituted; heteroaryl, provided that a heteroatom of the heteroaryl is not bonded directly with C.dbd.C; mixed alkylaryl, provided, first, that no heteroatom is bonded to C.dbd.C and, second, that either an aryl moiety of the mixed alkylaryl is directly bonded to C.dbd.C or that any aryl moiety is separated from C.dbd.C by at least one sp.sup.3 carbon atom and, where only one sp.sup.3 hybridized carbon atom intervenes between C.dbd.C and an aryl moiety, that intervening sp.sup.3 carbon must be fully substituted. Y is a substituent containing any of the groups described above for R.sub.1 and R.sub.2, except that Y cannot be hydrogen, and bearing a functional group suitable for binding to protein under conditions that preserve the biological activity of the protein. The compounds of formulas I and II can be coupled to proteins such as monoclonal antibodies to provide reagents for diagnostic and therapeutic applications. Also metalated precursors of compounds I and II, as well as radiopharmaceutical reagent kits containing any of the subject small molecules.
REFERENCES:
patent: 4450149 (1984-05-01), Kabalka
patent: 4524059 (1985-06-01), Elmaleh et al.
patent: 4541957 (1985-09-01), Nakatsuka et al.
patent: 4725426 (1988-02-01), Hofmeister et al.
Hanson, R. N., et al., E-17.alpha.[.sup.125 I]iodovinylestradiol: an estrogen-receptor-seeking radiopharmaceutical, J. Nucl. Med., 23(5):431-436, 1982.
Hanson, R. N., et al., Radiohalodestannylation: synthesis of .sup.125 I-labeled 17.alpha.-E-iodovinylestradiol, Int. J. Appl. Radiat. Isot. 35(8):810-812, 1984.
Hoyte, R. M., et al., Synthesis and evaluation of potential radioligands for the progesterone receptor, J. Med. Chem. 28(11):1695-1699, 1985.
Hanson, R. N., et al., E-17.alpha.-[.sup.125 I]iodovinylestradiol: an estrogen-receptor-seeking radiopharmaceutical, J. Nucl. Med. 23(5):431-436, 1982.
March, J., Advanced Organic Chemistry, Third Edition, John Wiley & Sons, pp. 664-666, 1985.
Goodman, M. M., et al., Design, Synthesis and Evaluation of 2-deoxy-2-iodovinyl-branched carbohydrates as potential brain imaging agents, Proceedings of the Sixth International Symposium on Radiopharmaceutical Chemistry, Boston, MA, Jul. 29-Jun. 3, 1986, in Journal of Labelled Compounds and Radiopharmaceuticals 23:243-245, 1987.
Salisbury, L. E., Kinetic Study of the Relationship of Rearrangement to Racemization in Certain Dibenzo [a,e]cyclooctatetraenes, J. Org. Chem. 43(26):4991-4995, 1978.
Schwartz, J., and J. A. Labinger, Hydrozirconation: a new transition metal reagent for Organic Synthesis, Agnew Chem. Int. Ed. Engl. 15(6):333-340, 1976.
Seyferth, D., "Vinyl Derivatives of the Metals, III., Vinylmercuric Halides," The Journal of Organic Chemistry 22:478, 1957.
Larock, R. C., et al., Reaction of 2-alkenyl-1,3,2-benzodioxaboroles with mercuric acetate: a convenient stereospecific procedure for the conversion of alkynes into alkenylmercuric salts, J. Amer. Chem. Soc. 94(12):4371-4373, 1982.
Kabalka, G. W., et al., Rapid and Mild Syntheses of Radioiodinated Estrogen Derivatives via Organoborane Technology, in Applications of Nuclear and Radiochemistry, M. Lambrecth and N. Morcos, Eds., Brookhaven National Laboratory, Pergamon Press, pp. 197-203, 1982.
Kabalka, G. W., et al., A Convenient Procedure for the Synthesis of Vinyl Iodides via the Reaction of Iodine Monochloride with Vinylboronic Acids, Synthetic Communications 11(3):247-251, 1981.
Hadley Stephen W.
Wilbut Daniel S.
Maples John S.
NeoRx Corporation
LandOfFree
Vinyl substituted radiohalogen and methods of use conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vinyl substituted radiohalogen and methods of use conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vinyl substituted radiohalogen and methods of use conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1587938